83 related articles for article (PubMed ID: 2900765)
1. 8-Bromo cyclic GMP mimics the actions of nitroglycerin in modulating responses produced by full and partial alpha-adrenoceptor agonists in canine saphenous vein.
Eskinder H; Gross GJ
Eur Heart J; 1988 Jan; 9 Suppl A():11-5. PubMed ID: 2900765
[TBL] [Abstract][Full Text] [Related]
2. 8-Bromo cyclic guanosine monophosphate mimics the actions of nitroglycerin on alpha-adrenergic mechanisms in canine saphenous vein.
Eskinder H; Gross GJ
Pharmacology; 1987; 35(1):16-23. PubMed ID: 2819902
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of alpha-1 vs. alpha-2 adrenoceptor-mediated responses in canine saphenous vein by nitroglycerin.
Eskinder H; Gross GJ
J Pharmacol Exp Ther; 1986 Aug; 238(2):515-21. PubMed ID: 3016240
[TBL] [Abstract][Full Text] [Related]
4. Alpha adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: sensitivity to blockade by nitroglycerin.
Eskinder H; Hillard CJ; Olinger GN; Christensen CW; Baker JE; Warltier DC; Gross GJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):941-8. PubMed ID: 2905005
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of alpha-adrenoceptor agonists to the calcium channel activator, Bay K 8644, in canine saphenous vein.
Eskinder H; Gross GJ
Pharmacology; 1987; 35(5):272-8. PubMed ID: 2447595
[TBL] [Abstract][Full Text] [Related]
6. Relationship between alpha 2-adrenoceptor occupancy and response for B-HT 933 in canine saphenous vein.
Ruffolo RR; Zeid RL
Eur J Pharmacol; 1985 May; 111(2):267-71. PubMed ID: 2862046
[TBL] [Abstract][Full Text] [Related]
7. Relationship between alpha adrenoceptor occupancy and response for the alpha-1 adrenoceptor agonist, cirazoline, and the alpha-2 adrenoceptor agonist, B-HT 933, in canine saphenous vein.
Ruffolo RR; Zeid RL
J Pharmacol Exp Ther; 1985 Dec; 235(3):636-43. PubMed ID: 2867204
[TBL] [Abstract][Full Text] [Related]
8. Effects of glutathione S-transferase inhibitors on nitroglycerin action in pig isolated coronary arteries.
Matsuzaki T; Sakanashi M; Nakasone J; Noguchi K; Miyagi K; Sakanashi M; Kukita I; Aniya Y; Sakanashi M
Clin Exp Pharmacol Physiol; 2002 Dec; 29(12):1091-5. PubMed ID: 12390297
[TBL] [Abstract][Full Text] [Related]
9. Effect of diltiazem upon contractile responses to phenylephrine, cirazoline, Sgd 101/75, St 587 and B-HT 920 in rabbit aorta and dog saphenous vein preparations.
Bou J; Massingham R
Eur J Pharmacol; 1986 Mar; 121(3):319-25. PubMed ID: 2870931
[TBL] [Abstract][Full Text] [Related]
10. An in vitro quantitative analysis of the alpha adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity.
Kenakin TP
J Pharmacol Exp Ther; 1981 Feb; 216(2):210-9. PubMed ID: 6109772
[TBL] [Abstract][Full Text] [Related]
11. Insights into the unusual alpha adrenoceptor subtype in dog saphenous vein using phenoxybenzamine.
Low AM; Lu-Chao H; Loke JC; Kwan CY; Daniel EE
J Pharmacol Exp Ther; 1999 Jan; 288(1):148-56. PubMed ID: 9862765
[TBL] [Abstract][Full Text] [Related]
12. Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.
Andrews KL; Lumsden NG; Farry J; Jefferis AM; Kemp-Harper BK; Chin-Dusting JP
Clin Sci (Lond); 2015 Jul; 129(2):179-87. PubMed ID: 25728899
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of glyceryl trinitrate on alpha-adrenoceptor mediated contraction in the human internal mammary artery.
He GW; Shaw J; Yang CQ; Hughes C; Thomson D; McCaughan B; Hendle PN; Baird DK
Br J Clin Pharmacol; 1992 Sep; 34(3):236-43. PubMed ID: 1356404
[TBL] [Abstract][Full Text] [Related]
14. Alpha-adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production.
Hicks PE; Barras M; Herman G; Mauduit P; Armstrong JM; Rossignol B
Br J Pharmacol; 1991 Jan; 102(1):151-61. PubMed ID: 1675142
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
16. Nimodipine and inhibition of alpha adrenergic activation of the isolated canine saphenous vein.
Cooke JP; Rimele TJ; Flavahan NA; Vanhoutte PM
J Pharmacol Exp Ther; 1985 Sep; 234(3):598-602. PubMed ID: 2863368
[TBL] [Abstract][Full Text] [Related]
17. Role of PKC in the attenuation of the cGMP-mediated relaxation of skinned resistance artery smooth muscle seen in glyceryl-trinitrate-tolerant rabbit.
Nakano Y; Kusama N; Kajikuri J; Suzuki Y; Kanmura Y; Itoh T
Br J Pharmacol; 2004 Feb; 141(3):391-8. PubMed ID: 14718264
[TBL] [Abstract][Full Text] [Related]
18. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
Oriowo MA; Hieble JP; Ruffolo RR
Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitroprusside, glyceryl trinitrate, and 8-bromo cyclic GMP on phosphorylase a formation and myosin light chain phosphorylation in rat aorta.
Johnson RM; Lincoln TM
Mol Pharmacol; 1985 Mar; 27(3):333-42. PubMed ID: 2983183
[TBL] [Abstract][Full Text] [Related]
20. Halothane selectively attenuates alpha 2-adrenoceptor mediated vasoconstriction, in vivo and in vitro.
Larach DR; Schuler HG; Derr JA; Larach MG; Hensley FA; Zelis R
Anesthesiology; 1987 Jun; 66(6):781-91. PubMed ID: 2884899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
